What are Comparables in Valuation?

Valuing a company is hard. You don't know the future. You can't perfectly forecast cash flows or growth rates. So instead of building an elaborate fortress of assumptions, many professional investors turn to a simpler idea: find companies similar to the target, observe what the market pays for them, and use those prices as a reference point for your own valuation. This approach—using the prices of comparable companies to estimate value—is called comparable company analysis, or "comps."

Comparables are one of the three pillars of valuation work, alongside DCF (discounted cash flow models) and precedent transactions. They are used by equity researchers, investment bankers, private equity firms, and institutional investors to triangulate what a company ought to be worth. And because they are grounded in observable market prices, they carry an authority that forecasts alone cannot: they are not pure conjecture; they represent money actually changing hands.

Quick definition

Comparable company analysis is a valuation method that identifies companies with similar financial and operational characteristics, extracts their valuation multiples (such as EV/EBITDA, P/E, or EV/Sales), and applies those multiples to the target company's financial metrics to estimate enterprise value or equity value.

Key takeaways

• Comparables derive value from observable market prices of similar companies, not from projections alone
• The two main categories are trading comps (current market prices of public companies) and transaction comps (prices paid in M&A deals)
• A valuation multiple is a ratio of enterprise value (or equity value) to a financial metric—EBITDA, revenue, earnings, free cash flow, or book value
• Building a good comp set requires identifying peers that share industry, scale, growth profile, and profitability characteristics
• Comparables are fastest to calculate and easiest to defend with clients; DCF requires more judgment but captures idiosyncratic value drivers
• Comps work best for mature, stable businesses; they struggle with high-growth, unprofitable, or one-of-a-kind firms

The core logic: market consensus as anchor

At its heart, comparable company analysis rests on this principle: the market has already priced similar companies; use those prices as a benchmark. If Company A trades at 12x forward earnings and Company B is nearly identical in growth, profitability, and risk, then Company B should also trade at roughly 12x forward earnings (all else equal). If it trades at 8x, it may be undervalued. If it trades at 16x, it may be overvalued.

This is not claiming the market is always right. It is claiming that relative prices within a peer group are more reliable than absolute guesses about cash flow terminal values or discount rates. The market may be irrationally exuberant about a whole industry, but it is less likely to be irrationally exuberant about one company while pricing its twin at half the price.

This logic works because comparables anchor on something observable: the price at which someone, somewhere, bought or sold a stock today. A DCF model, by contrast, anchors on forecasts—revenue growth, margins, capex, terminal growth rates—each of which is a guess. Forecasts are necessary, but they are guesses. Market prices are facts.

Types of comparables: trading vs transaction

There are two main sources of comparable company multiples:

Trading comps are multiples derived from the current stock prices of publicly traded peers. If you want to value Company X, you look at what the market is paying for Company Y, Company Z, and Company W today. These are live, real-time data points. They move every second the market is open. Trading comps are fast to gather and easy to update.

Transaction comps (also called "precedent transactions") are multiples paid in actual M&A deals—an acquisition, a merger, a leveraged buyout. When Buyer acquired Target for $10 billion and Target had $2 billion of EBITDA, the implied multiple was 5x EBITDA. These are historical, real money prices, but they are one-off events. An M&A multiple is often higher than a trading multiple for the same company because the buyer pays a control premium.

Both types are essential. Trading comps tell you what the public market thinks. Transaction comps tell you what strategic and financial buyers are willing to pay. Together, they bound the valuation range.

What is a valuation multiple?

A valuation multiple is a fraction: price (or enterprise value) in the numerator, and a financial metric in the denominator. Common multiples include:

• P/E ratio (Price-to-Earnings): Market cap divided by net income. Works for profitable companies.
• EV/EBITDA: Enterprise value divided by earnings before interest, taxes, depreciation, and amortization. Works for most companies; eliminates debt and tax differences.
• EV/Sales (Price-to-Sales): Enterprise value divided by revenue. Works for unprofitable companies.
• P/B ratio (Price-to-Book): Market cap divided by book value of equity. Common for financial institutions and asset-intensive businesses.
• EV/FCF (EV divided by Free Cash Flow): Enterprise value divided by free cash flow. Focuses on true cash earnings.
• PEG ratio: P/E divided by growth rate. Adjusts for growth.

The denominator is usually chosen to match the company's profile. For a mature, stable manufacturing company, EV/EBITDA is intuitive because EBITDA is stable and comparable across peers. For a high-growth SaaS company that may not be profitable, EV/Sales or a revenue multiple is more useful because it doesn't get knocked sideways by different depreciation policies.

Trading comps in practice

Imagine you are valuing Acme Manufacturing, a mid-cap industrial equipment maker. You identify five public peers: Competitor A, Competitor B, Competitor C, Competitor D, and Competitor E. You gather their current stock prices, calculate their market caps, and extract their EBITDA from their latest quarter or annual report. You then calculate each peer's EV/EBITDA multiple:

Company	Market Cap ($B)	Net Debt ($B)	Enterprise Value ($B)	EBITDA ($B)	EV/EBITDA
Competitor A	8.5	1.2	9.7	1.1	8.8x
Competitor B	6.2	0.8	7.0	0.9	7.8x
Competitor C	10.1	1.5	11.6	1.3	8.9x
Competitor D	5.8	0.5	6.3	0.75	8.4x
Competitor E	7.3	0.9	8.2	0.95	8.6x
Median	—	—	—	—	8.6x
Mean	—	—	—	—	8.7x

The peer set trades at a median of 8.6x EV/EBITDA. Acme Manufacturing reported $1.2 billion of EBITDA last year. If you apply the median multiple:

Enterprise Value = $1.2B × 8.6x = $10.3B

If Acme has $1.0B of net debt, equity value is $10.3B − $1.0B = $9.3B. If there are 500 million shares outstanding, implied price per share is $18.60.

That is a trading comp valuation.

Transaction comps in practice

Now imagine an investment bank is advising on the sale of Widget Corp, a mid-market software company. In the past three years, five comparable software companies have been acquired:

Deal	Target	Buyer	EV ($M)	Revenue ($M)	EV/Revenue
2022	SoftA	Strategic	450	80	5.6x
2023	SoftB	PE Fund 1	310	62	5.0x
2023	SoftC	Strategic	520	95	5.5x
2024	SoftD	PE Fund 2	280	60	4.7x
2024	SoftE	Strategic	650	110	5.9x
Median	—	—	—	—	5.5x

The last five deals valued the targets at a median EV/Revenue of 5.5x. Widget Corp is projected to have $100M of revenue this year. Using a 5.5x multiple:

Enterprise Value = $100M × 5.5x = $550M

This is a transaction comp valuation. It is typically higher than trading comps for the same industry, because M&A buyers pay a premium to gain control and realize synergies.

Why comparables matter

Comparables have several strengths over DCF models:

1. Speed: You can value a company in minutes using trading comps. A DCF model takes days to build carefully.
2. Defensibility: Multiples are based on observable market prices, not personal forecasts. It is hard to argue with "the peer set trades at 12x earnings."
3. Reality check: A comp valuation is a sanity check on a DCF model. If DCF says the stock is worth $50 but comps suggest $30, you should ask why.
4. No forecast needed: You don't need to project earnings five years out. You just need a current financial metric.
5. Market discipline: Comparables respect what the market is actually paying. They are less prone to wild overconfidence in a forecast.

But comparables also have weaknesses:

1. Assumes peer similarity: Real companies are not identical. Peer sets are always imperfect. If your "comparable" grows at 15% and your target grows at 5%, the multiple should be lower.
2. Market-driven bias: If the whole peer group is overvalued (or undervalued), your comp valuation will be too. Comparables do not tell you if the entire industry is cheap or expensive in absolute terms.
3. Circular logic: You are valuing Company X by asking "what does the market think Company X's peer is worth?" If the market is wrong, your valuation is wrong.
4. Sensitive to time: Market multiples change by the hour. A comp valuation done on Monday may be stale by Friday.
5. Struggles with outliers: If your target is a unique company with no true peers (e.g., the first mover in a new market, a serial acquirer), comparables break down.

How comparables fit into the valuation toolkit

Most professional valuations use multiple methods:

• DCF first: Build a detailed cash flow forecast and calculate intrinsic value.
• Comps second: Run a comp analysis as a reality check and a market price anchor.
• Transactions third: If relevant, gather M&A multiples to see what strategic buyers are paying.
• Reconcile: If all three methods point to a similar range, confidence rises. If they diverge, dig deeper.

The goal is not to pick one method and declare victory. It is to triangulate using all available evidence. A stock might appear cheap on comps but expensive on DCF; that gap may be because the market is undervaluing growth potential (and DCF is right) or because your growth forecast is too optimistic (and comps are right).

A visual framework for comparables

Real-world examples

Example 1: Valuing Netflix using trading comps

In 2024, Netflix trades at approximately 40x forward earnings, substantially higher than the broader market average (19x). Why? The market is pricing in Netflix's revenue growth of 13% and operating margin expansion to 20%+. When you identify comparable media and entertainment stocks, Netflix trades at a premium to legacy media (Disney, Paramount) but at a discount to high-growth SaaS companies (ServiceTitan, Monday.com at 60+x). The comps framework explains this: Netflix is a premium growth stock, but not quite "SaaS-grade" premium.

Example 2: Valuing Berkshire Hathaway

Berkshire Hathaway is difficult to value using trading comps because it has no true peer. It is a diversified holding company with insurance, energy, utilities, and equity investments. When analysts value Berkshire, they often turn to P/B (price-to-book) because Berkshire has historically been transparent about book value per share and its performance relative to the S&P 500. Berkshire has traded at 1.3x to 1.6x book value over the past decade. Using this multiple and Berkshire's latest book value anchors the valuation, but it is a rough anchor because Berkshire's intrinsic value per dollar of book is not constant—it improves when Buffett finds great investments and deteriorates if he struggles to deploy capital.

Example 3: Valuing a pre-revenue biotech

A small biotech firm with one clinical-stage drug candidate has no earnings, no revenue, and sometimes no near-term path to either. Traditional multiples (P/E, EV/EBITDA) are useless. Instead, analysts might look at comparable M&A deals: "What did strategic pharma companies pay for other Phase 2 assets with similar target indications?" This gives a range of prices per preclinical or clinical asset. Combined with a DCF model of the pipeline (using probability-adjusted cash flows), comps constrain the valuation.

Common mistakes in comparable analysis

Mistake 1: Forcing peer comparability

Analysts often stretch definitions of "comparable" to include companies that are only superficially similar. A biotech company working on immunotherapy might be grouped with a biotech company working on small-molecule drugs, but they have different risk profiles, development timelines, and capital efficiency. Forcing them into one peer set obscures real differences.

Mistake 2: Using mean instead of median

One outlier—a stock that is priced at 2x or 25x earnings due to a special situation—can skew the mean multiple upward or downward. The median is more robust. Always use median; use mean only if you have reason to believe the distribution is normal and outliers are exceptions.

Mistake 3: Failing to adjust for differences

Just because two companies are in the same industry does not mean they trade at the same multiple. One might have better margins, faster growth, or lower debt. Ignoring these differences leads to crude valuations. Professionals adjust multiples for growth, quality, and leverage; beginners often do not.

Mistake 4: Stale data

Multiples change every day the market is open. A comp valuation done with Friday's data is not the same as one done with Monday's data, especially in volatile markets. Always use the most recent data available.

Mistake 5: Confusing market price with intrinsic value

Comps tell you what the market is paying, not what a company is intrinsically worth. If the entire peer group is overvalued, your comps valuation will be too high. Use comps to triangulate, not to proclaim truth.

FAQ

Q: What is the difference between enterprise value and equity value?

A: Enterprise value (EV) is the value of the business itself, independent of its capital structure. It is market cap plus net debt. Equity value is what remains for shareholders after creditors are paid. EV/EBITDA and EV/Sales are "entity multiples" because they value the whole enterprise; P/E and P/B are "equity multiples" because they value just the equity portion.

Q: Why use EBITDA instead of net income?

A: Different companies have different tax rates, depreciation policies, and capital structures. By using EBITDA, you isolate the operating performance. A company with high depreciation (capital-intensive) will have lower net income than EBITDA; a company with high debt will have lower net income due to interest. EV/EBITDA strips these differences away and lets you compare apples to apples.

Q: Should I use forward or trailing multiples?

A: Forward multiples (based on next year's earnings or EBITDA) are generally preferred because they look ahead. Trailing multiples (based on the last twelve months) can be stale, especially for a company in transition. Use forward when you have good visibility; use trailing when the business is in flux.

Q: How many peers should I include in my comp set?

A: Five to ten peers is typical. Too few (one or two) and you have no diversification; one outlier skews the result. Too many (twenty+) and you are diluting the "comparable" standard—you are including companies that are only loosely related. Aim for quality over quantity.

Q: What if my target company is much smaller (or larger) than its peers?

A: Size differences often justify multiple adjustments. Smaller companies typically trade at lower multiples than larger ones due to liquidity risk, earnings volatility, and scale disadvantages. You might need to apply a size discount or use a separate small-cap peer group.

Q: How do I use comps if my target is in a declining industry?

A: You use them, but with caution. Declining industries see multiple compression (lower multiples over time). Comps will reflect that. You should also ask whether the decline is structural and permanent (in which case the entire peer group is at risk) or cyclical (in which case multiples may rebound).

Q: Can I use international peers in my comp set?

A: Yes, especially for large multinational companies. However, you must account for differences in accounting standards (IFRS vs GAAP), tax regimes, and regulatory environments. A European bank and a U.S. bank may have very different capital requirements and thus different ROE targets, which would justify different multiples.

Related concepts

• Precedent transactions: Historical M&A multiples, which are usually higher than trading multiples because they include a control premium
• Valuation multiples: The ratios (P/E, EV/EBITDA, EV/Sales) used in comps analysis
• Peer group screening: The process of identifying which companies should be included in the comp set
• Multiple expansion and contraction: When a stock's multiple rises (expansion) or falls (contraction), independent of earnings growth
• DCF as a benchmark: Using discounted cash flow to sanity-check comp valuations and vice versa

Summary

Comparable company analysis is one of the three pillars of valuation. It answers the question: "What is the market paying for similar companies?" By identifying a peer group, extracting their multiples, and applying those multiples to your target's financials, you can quickly estimate intrinsic value. Trading comps use current market prices; transaction comps use historical M&A prices. Both are useful, and both have limits. Comparables are fastest to calculate and easiest to defend, but they assume peer similarity and depend on the market being reasonably efficient. Used in combination with DCF and precedent transactions, comps are a powerful tool for anchoring your valuation in observable reality.

Next

Read the next article, Trading comps vs transaction comps, to dive deeper into the two main sources of comparable multiples—and when to use each one.